FDA recall D-0365-2024

Contract Pharmaceuticals Limited Canada · Class III · drug

Product

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Reason for recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Distribution

Nationwide in the U.S. and Puerto Rico

Key facts

Status
Ongoing
Initiation date
2024-02-20
Report date
2024-03-13
Voluntary/Mandated
Voluntary: Firm initiated
Location
Mississauga, Canada

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0365-2024